Apimeds Pharmaceuticals US (APUS) Shares Outstanding (Entity) (2023 - 2025)
Apimeds Pharmaceuticals US (APUS) Shares Outstanding (Entity) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.27 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 43.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Apimeds Pharmaceuticals US | 61.48 Mn | 61.48 Mn | - | 12.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.58 Mn |
| Sep 30, 2025 | 12.58 Mn |
| Jun 30, 2025 | 10.37 Mn |
| Mar 31, 2025 | 7.90 Mn |
| Dec 31, 2024 | 7.90 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Mar 31, 2024 | 7.90 Mn |
| Dec 31, 2023 | 4.60 Mn |